The Novel Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Alpelisib Effectively Inhibits Growth of PTEN-Haploinsufficient Lipoma Cells
Germline mutations in the tumor suppressor gene <i>PTEN</i> cause PTEN Hamartoma Tumor Syndrome (PHTS). Pediatric patients with PHTS frequently develop lipomas. Treatment attempts with the mTORC1 inhibitor rapamycin were unable to reverse lipoma growth. Recently, lipomas associated with...
Main Authors: | Anna S. Kirstein, Adrien Augustin, Melanie Penke, Michele Cea, Antje Körner, Wieland Kiess, Antje Garten |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/10/1586 |
Similar Items
-
A new human adipocyte model with PTEN haploinsufficiency
by: Franziska Kässner, et al.
Published: (2020-01-01) -
Gingival Overgrowths Revealing <i>PTEN</i> Hamartoma Tumor Syndrome: Report of Novel <i>PTEN</i> Pathogenic Variants
by: Samuele Sutera, et al.
Published: (2022-12-01) -
Phenotype-Driven Diagnostic of <i>PTEN</i> Hamartoma Tumor Syndrome: Macrocephaly, But Neither Height nor Weight Development, Is the Important Trait in Children
by: Michaela Plamper, et al.
Published: (2019-07-01) -
PTEN: multiple functions in human malignant tumors
by: Michele eMilella, et al.
Published: (2015-02-01) -
Distinguishing between PTEN clinical phenotypes through mutation analysis
by: Stephanie Portelli, et al.
Published: (2021-01-01)